Dose-Escalation Study to Assess the Safety, Tolerability, and Pharmacokinetics From Single Dose of Intramuscular (IM) and Subcutaneous (SC) Donepezil (GB-5001) Injections Versus Donepezil Oral Tablet (Aricept®) in Healthy Male Volunteers
Clinical trial NCT06127368 · UNKNOWN
Trial details
- NCT number
- NCT06127368
- Sponsor
- G2GBio, Inc.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-01-03
- Primary completion
- 2024-09-17
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.